Literature DB >> 27003823

Curcumin Rescues a PINK1 Knock Down SH-SY5Y Cellular Model of Parkinson's Disease from Mitochondrial Dysfunction and Cell Death.

Celia van der Merwe1, Hayley Christy van Dyk2, Lize Engelbrecht3, Francois Hendrikus van der Westhuizen2, Craig Kinnear4,5, Ben Loos6, Soraya Bardien7.   

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder characterised by the loss of dopaminergic neurons in the substantia nigra. Mutations in the PINK1 gene result in an autosomal recessive form of early-onset PD. PINK1 plays a vital role in mitochondrial quality control via the removal of dysfunctional mitochondria. The aim of the present study was to create a cellular model of PD using siRNA-mediated knock down of PINK1 in SH-SY5Y neuroblastoma cells The possible protective effects of curcumin, known for its many beneficial properties including antioxidant and anti-inflammatory effects, was tested on this model in the presence and absence of paraquat, an additional stressor. PINK1 siRNA and control cells were separated into four treatment groups: (i) untreated, (ii) treated with paraquat, (iii) pre-treated with curcumin then treated with paraquat, or (iv) treated with curcumin. Various parameters of cellular and mitochondrial function were then measured. The PINK1 siRNA cells exhibited significantly decreased cell viability, mitochondrial membrane potential (MMP), mitochondrial respiration and ATP production, and increased apoptosis. Paraquat-treated cells exhibited decreased cell viability, increased apoptosis, a more fragmented mitochondrial network and decreased MMP. Curcumin pre-treatment followed by paraquat exposure rescued cell viability and increased MMP and mitochondrial respiration in control cells, and significantly decreased apoptosis and increased MMP and maximal respiration in PINK1 siRNA cells. These results highlight a protective effect of curcumin against mitochondrial dysfunction and apoptosis in PINK1-deficient and paraquat-exposed cells. More studies are warranted to further elucidate the potential neuroprotective properties of curcumin.

Entities:  

Keywords:  Apoptosis; Curcumin; Mitochondrial dysfunction; PINK1; Parkinson’s disease

Mesh:

Substances:

Year:  2016        PMID: 27003823     DOI: 10.1007/s12035-016-9843-0

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  35 in total

1.  Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients.

Authors:  Aleksandar Rakovic; Anne Grünewald; Philip Seibler; Alfredo Ramirez; Norman Kock; Slobodanka Orolicki; Katja Lohmann; Christine Klein
Journal:  Hum Mol Genet       Date:  2010-05-27       Impact factor: 6.150

2.  Curcumin attenuates aluminum-induced oxidative stress and mitochondrial dysfunction in rat brain.

Authors:  Pooja Khanna Sood; Uma Nahar; Bimla Nehru
Journal:  Neurotox Res       Date:  2011-06-09       Impact factor: 3.911

Review 3.  Advances in the genetics of Parkinson disease.

Authors:  Joanne Trinh; Matt Farrer
Journal:  Nat Rev Neurol       Date:  2013-07-16       Impact factor: 42.937

4.  Mechanism of cytotoxicity of paraquat.

Authors:  Tetsuhito Fukushima; Keiko Tanaka; Heejin Lim; Masaki Moriyama
Journal:  Environ Health Prev Med       Date:  2002-07       Impact factor: 3.674

Review 5.  Mitochondrial quality control: insights on how Parkinson's disease related genes PINK1, parkin, and Omi/HtrA2 interact to maintain mitochondrial homeostasis.

Authors:  Ruben K Dagda; Charleen T Chu
Journal:  J Bioenerg Biomembr       Date:  2009-12       Impact factor: 2.945

6.  Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.

Authors:  Min S Wang; Shanta Boddapati; Sharareh Emadi; Michael R Sierks
Journal:  BMC Neurosci       Date:  2010-04-30       Impact factor: 3.288

Review 7.  Neuroprotective properties of curcumin in Alzheimer's disease--merits and limitations.

Authors:  Dawn Chin; Patricia Huebbe; Kathrin Pallauf; Gerald Rimbach
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

8.  Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells.

Authors:  Jun Wang; Xi-Xun Du; Hong Jiang; Jun-Xia Xie
Journal:  Biochem Pharmacol       Date:  2009-04-08       Impact factor: 5.858

9.  Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin.

Authors:  Elena Ziviani; Ran N Tao; Alexander J Whitworth
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

10.  Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy.

Authors:  Matthew E Gegg; J Mark Cooper; Kai-Yin Chau; Manuel Rojo; Anthony H V Schapira; Jan-Willem Taanman
Journal:  Hum Mol Genet       Date:  2010-09-24       Impact factor: 6.150

View more
  26 in total

1.  Loss of PINK1 causes age-dependent decrease of dopamine release and mitochondrial dysfunction.

Authors:  Lianteng Zhi; Qi Qin; Tanziyah Muqeem; Erin L Seifert; Wencheng Liu; Sushuang Zheng; Chenjian Li; Hui Zhang
Journal:  Neurobiol Aging       Date:  2018-11-02       Impact factor: 4.673

Review 2.  Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases.

Authors:  Robert B Cameron; Craig C Beeson; Rick G Schnellmann
Journal:  J Med Chem       Date:  2016-09-27       Impact factor: 7.446

Review 3.  Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.

Authors:  Johant Lakey-Beitia; Andrea M Burillo; Giovanni La Penna; Muralidhar L Hegde; K S Rao
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

4.  Compounds that extend longevity are protective in neurodegenerative diseases and provide a novel treatment strategy for these devastating disorders.

Authors:  Sonja K Soo; Paige D Rudich; Annika Traa; Namasthée Harris-Gauthier; Hazel J Shields; Jeremy M Van Raamsdonk
Journal:  Mech Ageing Dev       Date:  2020-06-28       Impact factor: 5.432

Review 5.  Using Drosophila as a platform for drug discovery from natural products in Parkinson's disease.

Authors:  Urmila Maitra; Lukasz Ciesla
Journal:  Medchemcomm       Date:  2019-04-30       Impact factor: 3.597

6.  Protective effect of curcumin against rotenone-induced substantia nigra pars compacta neuronal dysfunction.

Authors:  L V Darbinyan; K V Simonyan; L E Hambardzumyan; L P Manukyan; S H Badalyan; V H Sarkisian
Journal:  Metab Brain Dis       Date:  2022-03-03       Impact factor: 3.584

7.  Attenuation of Endoplasmic Reticulum Stress, Impaired Calcium Homeostasis, and Altered Bioenergetic Functions in MPP+-Exposed SH-SY5Y Cells Pretreated with Rutin.

Authors:  Adaze Bijou Enogieru; William Lloyd Haylett; Hayley Christy Miller; Francois Hendrikus van der Westhuizen; Donavon Charles Hiss; Okobi Eko Ekpo
Journal:  Neurotox Res       Date:  2019-05-04       Impact factor: 3.911

Review 8.  The delta-opioid receptor and Parkinson's disease.

Authors:  Jin-Zhong Huang; Yi Ren; Yuan Xu; Tao Chen; Terry C Xia; Zhuo-Ri Li; Jian-Nong Zhao; Fei Hua; Shi-Ying Sheng; Ying Xia
Journal:  CNS Neurosci Ther       Date:  2018-08-03       Impact factor: 5.243

9.  Inhibition of γH2AX, COX-2 and regulation of antioxidant enzymes in MPP+-exposed SH-SY5Y cells pre-treated with rutin.

Authors:  Adaze Bijou Enogieru; William Haylett; Donavon Hiss; Okobi Ekpo
Journal:  Metab Brain Dis       Date:  2021-05-12       Impact factor: 3.584

Review 10.  Natural products targeting mitochondria: emerging therapeutics for age-associated neurological disorders.

Authors:  Zhibin Liang; Antonio Currais; David Soriano-Castell; David Schubert; Pamela Maher
Journal:  Pharmacol Ther       Date:  2020-11-20       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.